These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The effects of willed movement therapy on AMPA receptor properties for adult rat following focal cerebral ischemia. Tang Q, Yang Q, Hu Z, Liu B, Shuai J, Wang G, Liu Z, Xia J, Shen X. Behav Brain Res; 2007 Aug 06; 181(2):254-61. PubMed ID: 17544158 [Abstract] [Full Text] [Related]
43. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. Zhao H, Sapolsky RM, Steinberg GK. J Cereb Blood Flow Metab; 2006 Sep 06; 26(9):1114-21. PubMed ID: 16736038 [Abstract] [Full Text] [Related]
47. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist. Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, Sakamoto S, Okada M, Shimizu-Sasamata M, Yamaguchi T. CNS Drug Rev; 2002 Sep 06; 8(4):337-52. PubMed ID: 12481190 [Abstract] [Full Text] [Related]
48. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura KI, Katayama Y. Neurol Res; 2001 Oct 06; 23(7):755-60. PubMed ID: 11680517 [Abstract] [Full Text] [Related]
50. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat. Okada M, Ueda H, Kometani M, Nakao K. Arzneimittelforschung; 1997 Jun 06; 47(6):703-5. PubMed ID: 9239446 [Abstract] [Full Text] [Related]
51. The effect of oxygen therapy on brain damage and cerebral pO(2) in transient focal cerebral ischemia in the rat. Hou H, Grinberg O, Williams B, Grinberg S, Yu H, Alvarenga DL, Wallach H, Buckey J, Swartz HM. Physiol Meas; 2007 Aug 06; 28(8):963-76. PubMed ID: 17664686 [Abstract] [Full Text] [Related]
52. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Jung KH, Chu K, Lee ST, Park HK, Kim JH, Kang KM, Kim M, Lee SK, Roh JK. Biochem Biophys Res Commun; 2009 Jan 16; 378(3):507-12. PubMed ID: 19056343 [Abstract] [Full Text] [Related]
53. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia. Umemura K, Shimakura A, Nakashima M. Brain Res; 1997 Oct 31; 773(1-2):61-5. PubMed ID: 9409705 [Abstract] [Full Text] [Related]
54. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Suzuki Y, Takagi Y, Nakamura R, Hashimoto K, Umemura K. Brain Res; 2003 Feb 21; 964(1):116-20. PubMed ID: 12573519 [Abstract] [Full Text] [Related]
55. Effects of status epilepticus early in life on susceptibility to ischemic injury in adulthood. Giorgi FS, Malhotra S, Hasson H, Velísková J, Rosenbaum DM, Moshé SL. Epilepsia; 2005 Apr 21; 46(4):490-8. PubMed ID: 15816942 [Abstract] [Full Text] [Related]
56. Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat. Vakili A, Zahedi khorasani M. Brain Res; 2007 May 04; 1144():186-91. PubMed ID: 17320054 [Abstract] [Full Text] [Related]
57. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. Graham SH, Chen J, Lan J, Leach MJ, Simon RP. J Pharmacol Exp Ther; 1994 May 04; 269(2):854-9. PubMed ID: 7910213 [Abstract] [Full Text] [Related]
58. Mexiletine and magnesium independently, but not combined, protect against permanent focal cerebral ischemia in Wistar rats. Lee EJ, Ayoub IA, Harris FB, Hassan M, Ogilvy CS, Maynard KI. J Neurosci Res; 1999 Nov 01; 58(3):442-8. PubMed ID: 10518118 [Abstract] [Full Text] [Related]